Putrinš, Marta <br/><br/>
Phenotypic heterogeneity enables uropathogenic Escherichia coli to evade killing by antibiotics and serum complement.  [electronic resource] 

 -  Infection and immunity  Mar 2015 
 - 1056-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-5522 
<br/><br/><label>Standard No.: </label>10.1128/IAI.02725-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amikacin--pharmacology<br/>Ampicillin--pharmacology<br/>Anti-Bacterial Agents--pharmacology<br/>Complement C3--pharmacology<br/>Drug Resistance, Bacterial<br/>Genetic Heterogeneity<br/>Genotype<br/>Humans<br/>Microbial Sensitivity Tests<br/>Microscopy, Fluorescence<br/>Norfloxacin--pharmacology<br/>Phenotype<br/>Uropathogenic Escherichia coli--drug effects